AbbVie Inc. Press Releases

ABBV 
$59.06
*  
0.39
0.66%
Get ABBV Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

AbbVie Declares Quarterly Dividend
9/19/2014 2:08:00 PM - PR Newswire

Hynes Keller & Hernandez, LLC Announces Investigation of World Acceptance Corp., PTC, Inc. and AbbVie Inc.
9/15/2014 7:13:00 AM - PR Newswire

Detailed Results from Biogen Idec and AbbVie’s Pivotal Phase 3 Decide Study Further Define the Efficacy and Safety Profile of ZINBRYTA™ (Daclizumab High-Yield Process)
9/12/2014 7:30:00 AM - Business Wire

AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy of HUMIRA® (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease
9/11/2014 3:00:00 AM - PR Newswire

AbbVie to Present at Morgan Stanley Global Healthcare Conference
9/5/2014 8:00:00 AM - PR Newswire

Revised GAAP earnings guidance for AbbVie Inc for the Financial Year ending December 31, 2014 and Third Quarter ending September 30, 2014; Confirms Adjusted Earnings Guidance
9/3/2014 4:05:00 PM - PR Newswire

AbbVie And Calico Announce A Novel Collaboration To Accelerate The Discovery, Development And Commercialization Of New Therapies
9/3/2014 1:00:00 PM - PR Newswire

Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology
9/3/2014 6:45:00 AM - PR Newswire

AbbVie Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards
8/18/2014 11:00:00 AM - PR Newswire

INVESTOR ALERT: Investigation of AbbVie Inc. Announced by The Wagner Firm
8/15/2014 3:12:00 PM - Business Wire

AbbVie Receives EMA and FDA Orphan Drug Designation for Investigational Compound ABT-414 in the Treatment of Glioblastoma Multiforme
8/4/2014 8:00:00 AM - PR Newswire

AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program
8/1/2014 10:00:00 AM - PR Newswire

AbbVie Reports Second-Quarter 2014 Financial Results
7/25/2014 7:47:00 AM - PR Newswire

AbbVie to Host Second-Quarter Earnings Conference Call
7/23/2014 12:44:00 PM - PR Newswire

Parkinson's Organizations Unite to Serve Patients and Families Through National "Partners in Parkinson's" Initiative
7/22/2014 11:00:00 AM - PR Newswire

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
7/18/2014 6:17:00 AM - PR Newswire

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
7/18/2014 6:14:00 AM - PR Newswire

AbbVie Announces Inaugural Week of Possibilities Volunteer Program to Support Six Schools in North Chicago, Ill., and Worcester, Mass.
7/16/2014 10:00:00 AM - PR Newswire

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
7/8/2014 7:50:00 AM - PR Newswire

AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) in Patients with Advanced Breast Cancer
6/26/2014 8:00:00 AM - PR Newswire

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
6/25/2014 8:45:00 AM - PR Newswire

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
6/25/2014 7:29:00 AM - PR Newswire